Warnex is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors.

> Read more about Warnex


Warnex Analytical Services provides quality control services to the pharmaceutical and biotechnology industries including traditional microbiology, chemistry, chromatography, and method development and validation.

> Learn more


Warnex Bioanalytical Services offers a range of services to both innovator and generic pharmaceutical companies, as well as to biotechnology companies, and specializes in bioavailability and bioequivalence studies.

> Learn more


Warnex Medical Laboratories specializes in laboratory testing services for the healthcare sector. Its key offering is the Prenatest® prenatal screening test, which enables a pregnant woman to assess the risk that the foetus she is carrying may be affected by some of the most common birth anomalies, such as Down syndrome.

> Learn more


Warnex on LinkedIn   Warnex on Facebook   Warnex on Twitter

Stock Quote

TSX: WNX   High: 0.025
Open: 0.025 Low: 0.025
Canadian $    Quotes are delayed.

Latest News

October 3, 2011
Warnex and deCODE Genetics Announce Exclusive Distribution Agreement for deCODE's Disease Risk Tests in Canada
September 26, 2011
Warnex Bioanalytical Services Receives DEQAS Certification for Vitamin D Analysis

Coming Events

October 23 - 27, 2011
American Association of Pharmaceuticals Scientists (AAPS) - Annual meeting
Washington D.C.
November 3 - 5, 2011
Family Medicine Forum
Montreal, QC